Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Islet Cell

Explore clinical trials studying Carcinoma, Islet Cell. Study availability and eligibility vary by location and protocol.

26 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Carcinoma, Islet Cell trial results

Completed

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

NCT02231723

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States
View Trial Details
Completed

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

NCT00427349

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations
  • Hematology Oncology Associates of Illinois - Berwyn Berwyn, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Hematology and Oncology Associates Chicago, Illinois, United States
  • Midwest Center for Hematology/Oncology Joliet, Illinois, United States
View all 112 locations
View Trial Details
Completed

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

NCT02259725

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • USC Norris Oncology Hematology-Newport Beach Newport Beach, California, United States
View Trial Details
Completed

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

NCT01465659

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +15 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

NCT00781911

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +19 more
Locations
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Aurora, Colorado, United States
  • ImClone Investigational Site Atlanta, Georgia, United States
View Trial Details

Related conditions